Krystal Biotech Inc (KRYS)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $9.05B
Last updated: Nov 17, 2026 at 4:20 PM ET
Krystal Biotech Inc (KRYS) Stock Chart
Krystal Biotech (KRYS) has a latest price of $297.90 on Nov 17, 2026, 22.1% below its 52-week high of $382.54. Its price rose 48.1% over the past 12 months. The month-end price rose 3,232.9% since Sep 2017, a compound annual rate of 47.1%.
Price Chart
From Sep 2017 to Oct 2026, its highest month-end close was $371.67 in Jun 2026 and its lowest $9.61 in Apr 2018, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart KRYS with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for KRYS.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 10.5%, and over 6 months it rose 2.1%. The month-end price rose 184.3% over the 3 years through Oct 2026, a compound annual rate of 41.7%.
| Period | Change |
|---|---|
| 1 month | -5.9% |
| 3 months | -10.5% |
| 6 months | +2.1% |
| 12 months | +48.1% |
| 12 months, with dividends | +48.1% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +184.3% | +41.7% |
| 5 years | +563.4% | +46.0% |
| Since Sep 2017 | +3,232.9% | +47.1% |
Price by Year
Its best calendar year was 2019, when the price rose 166.5%, and its weakest was 2020, when it rose 8.3%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $332.29 | +34.8% |
| 2025 | $246.54 | +57.4% |
| 2024 | $156.66 | +26.3% |
| 2023 | $124.06 | +56.6% |
| 2022 | $79.22 | +13.3% |
| 2021 | $69.95 | +16.6% |
| 2020 | $60.00 | +8.3% |
| 2019 | $55.38 | +166.5% |
| 2018 | $20.78 | +97.5% |
Trading Range
The price is 8.5% below its 50-day average of $325.56 and 3.8% below its 200-day average of $309.80.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $297.90 | |
| 52-week high | $382.54 | -22.1% |
| 52-week low | $203.18 | +46.6% |
| 50-day average | $325.56 | -8.5% |
| 200-day average | $309.80 | -3.8% |
Price Risk
Over 3 years, its largest fall from a peak was 42.3%.
| Measure | Value |
|---|---|
| 1-year beta | 0.76 |
| Largest fall, 1 year | -21.8% |
| Largest fall, 3 years | -42.3% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About KRYS
What is KRYS's 1-year price change?
Krystal Biotech's price rose 48.1% over the past 12 months. With dividends included, the 12-month total return was 48.1%.
What is KRYS's 5-year price change?
Krystal Biotech's month-end price rose 563.4% over the 5 years through Oct 2026, a compound annual rate of 46.0%. These figures leave out dividends.
What is KRYS's 52-week high and low?
Krystal Biotech's 52-week high is $382.54 and its 52-week low is $203.18. Its latest price of $297.90 on Nov 17, 2026 is 22.1% below the high.
What is KRYS's beta?
Krystal Biotech's 1-year beta against the S&P 500 is 0.76, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 21.8%.
Is the KRYS chart free?
Yes. Advanced Charting for KRYS is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
KRYS pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors